Search results
Results from the WOW.Com Content Network
Baxter's Marion, North Carolina, site is among the largest suppliers of sterile intravenous fluids and peritoneal dialysis solutions in the U.S., making 1.5 million bags daily — 60% of the ...
Baxter International was founded in 1931 by Donald Baxter, a Los Angeles-based medical doctor, as a manufacturer and distributor of intravenous therapy solutions. [4] Seeing a need for products closer to the Midwest, the company opened a manufacturing plant in Glenview, Illinois , in 1933. [ 4 ]
Gambro is a global medical technology company that manufactures products for dialysis treatment. The company is involved in developing, manufacturing and supplying products and therapies for kidney and liver dialysis, myeloma kidney therapy [clarify], and other extracorporeal therapies for chronic and acute patients.
Baxter International's North Cove manufacturing facility was affected by Hurricane Helene. ... site is among the largest suppliers of sterile intravenous fluids and peritoneal dialysis solutions ...
The cause for concern stems from the closing of the Baxter International plant in North Cove, North Carolina that makes IV fluids and peritoneal dialysis solutions which most of the country relies on.
Plasma-Lyte 148 is a market-specific solution available in the United Kingdom and Australia, among others and has the following composition: [citation needed] Sodium 140 mmol/L Potassium 5 mmol/L Magnesium 1.5 mmol/L Chloride 98 mmol/L Acetate 27 mmol/L Gluconate 23 mmol/L This solution is manufactured and marketed by Baxter International Inc. [4]
The plant, located in North Cove, 60 miles northeast of Asheville, primarily manufactures IV fluids and peritoneal dialysis solutions, according to Baxter. It is the largest manufacturer of such ...
Hemofiltration is sometimes used in combination with hemodialysis, when it is termed hemodiafiltration. Blood is pumped through the blood compartment of a high flux dialyzer, and a high rate of ultrafiltration is used, so there is a high rate of movement of water and solutes from blood to dialysate that must be replaced by substitution fluid that is infused directly into the blood line.